The future of the discovery depends on present safety testing TM

Latest News

Ask DRIK, what tox studies is needed? For a friendly chat at Oklahoma Pavilion: Booth 2621 – BIO 2018!

DRIK is a good example of a symbiotic business partner, pairing the time and money typically necessary for toxicology studies. Read more

Read more...
Animal tox studies CRO in life science summit this fall!

Drik will be attending The bionorthTX Annual iC3 Life Science Summit (October 26, 2016) in Dallas Texas, you’re invited to meet with us. Meet with us!

Read more...
Preclinical contract research organization showcase 2016!

Drik will be exhibiting at the BioNorth Texas Member Showcase – Sept 15th 2016 in Dallas,TX you’re invited to meet with us at the booth. Come research with us!

Read more...

OUR NICHE SERVICE IS THE KEY TO YOUR PRECLINICAL DRUG DEVELOPMENT SUCCESS

Drik is Oklahoma's first preclinical contract research organization ( CRO ) specializing in preclinical drug development. Drik preclinical testing services support an expanding range of in vitro testing and animal studies for preclinical drug discovery, cosmetic and chemical industries. Drik provides in vivo testing and toxicology tests in its laboratories including cell-based assays and cell assays exploring the causes of diseases and the potential safety concerns. We evaluate the toxicity of new agents using biological systems including animal models. Drik's premium niche service is in 3D Organotypic slice cultures, a leading industry initiative in providing a reliable de-risk strategy. Drik has also developed expeditious procedures for protocol review, Institutional Animal Care and Use Committee (IACUC) meets regularly each year to monitor the care and use of research animals. Drik has comprehensive processes and procedures in place for animal acclimation, dosing, animal observations, data recording, pathology, and report writing.

© 2014 DRIK LLC All right reserved  

Privacy & Policy/ Terms & Condition

Select Language